Nilotinib protects the murine liver from ischemia/reperfusion injury

Journal of Hepatology

Volumn 57, Issue 4, 2012, Pages 766-773

  Ocuin, Lee M ^a   Zeng, Shan ^a   Cavnar, Michael J ^a   Sorenson, Eric C ^a   Bamboat, Zubin M ^a   Greer, Jonathan B ^a   Kim, Teresa S ^a   Popow, Rachel ^a   Dematteo, Ronald P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

c Jun NH2 terminal kinase; Cytokines; Hepatocytes; Non parenchymal cells; p38 MAPK

Indexed keywords

ABELSON KINASE; ALANINE AMINOTRANSFERASE; COLONY STIMULATING FACTOR RECEPTOR; IMATINIB; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NILOTINIB; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN BAX; PROTEIN TYROSINE KINASE; STEM CELL FACTOR; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; HISTOPATHOLOGY; IN VITRO STUDY; LIVER CELL; LIVER HISTOLOGY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALANINE TRANSAMINASE; ANIMALS; APOPTOSIS; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CXCL2; ENZYME ACTIVATION; HEPATOCYTES; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MONOCYTES; PHOSPHORYLATION; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-ABL; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; REPERFUSION INJURY;

EID: 84866385959     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.05.012     Document Type: Article

References (49)

1. J.R. Klune, and A. Tsung Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements Surg Clin North Am 90 2010 665 677
2. A.J. Vardanian, R.W. Busuttil, and J.W. Kupiec-Weglinski Molecular mediators of liver ischemia and reperfusion injury: a brief review Mol Med 14 2008 337 345
3. J.S. Gujral, T.J. Bucci, A. Farhood, and H. Jaeschke Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology 33 2001 397 405
4. C. Dong, R.J. Davis, and R.A. Flavell MAP kinases in the immune response Annu Rev Immunol 20 2002 55 72
5. S. Kumar, J. Boehm, and J.C. Lee P38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases Nat Rev Drug Discov 2 2003 717 726
6. H. Malhi, and G.J. Gores Cellular and molecular mechanisms of liver injury Gastroenterology 134 2008 1641 1654
7. C.A. McCloskey, M.V. Kameneva, A. Uryash, D.J. Gallo, and T.R. Billiar Tissue hypoxia activates JNK in the liver during hemorrhagic shock Shock 22 2004 380 386
8. R.F. Schwabe, and D.A. Brenner Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways Am J Physiol Gastrointest Liver Physiol 290 2006 G583 G589
9. X. Wang, A. Destrument, and C. Tournier Physiological roles of MKK4 and MKK7: insights from animal models Biochim Biophys Acta 1773 2007 1349 1357
10. A. Wullaert, K. Heyninck, and R. Beyaert Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes Biochem Pharmacol 72 2006 1090 1101
11. E. De Smaele, F. Zazzeroni, S. Papa, D.U. Nguyen, R. Jin, and J. Jones Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling Nature 414 2001 308 313
12. R.F. Schwabe, H. Uchinami, T. Qian, B.L. Bennett, J.J. Lemasters, and D.A. Brenner Differential requirement for c-Jun NH2-terminal kinase in TNFalpha- and Fas-mediated apoptosis in hepatocytes FASEB J 18 2004 720 722
13. G. Tang, Y. Minemoto, B. Dibling, N.H. Purcell, Z. Li, and M. Karin Inhibition of JNK activation through NF-kappaB target genes Nature 414 2001 313 317
14. L.A. King, A.H. Toledo, F.A. Rivera-Chavez, and L.H. Toledo-Pereyra Role of p38 and JNK in liver ischemia and reperfusion J Hepatobiliary Pancreat Surg 16 2009 763 770
15. P.W. Manley, P. Drueckes, G. Fendrich, P. Furet, J. Liebetanz, and G. Martiny-Baron Extended kinase profile and properties of the protein kinase inhibitor nilotinib Biochim Biophys Acta 1804 2010 445 453
16. M.W. Deininger Nilotinib Clin Cancer Res 14 2008 4027 4031
17. Z.M. Bamboat, L.M. Ocuin, V.P. Balachandran, H. Obaid, G. Plitas, and R.P. DeMatteo Conventional DCs reduce liver ischemia/reperfusion injury in mice via IL-10 secretion J Clin Invest 120 2010 559 569
18. S. Suzuki, L.H. Toledo-Pereyra, F.J. Rodriguez, and D. Cejalvo Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine Transplantation 55 1993 1265 1272
19. Z.M. Bamboat, V.P. Balachandran, L.M. Ocuin, H. Obaid, G. Plitas, and R.P. DeMatteo Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury Hepatology 51 2010 621 632
20. L.M. Ocuin, Z.M. Bamboat, V.P. Balachandran, M.J. Cavnar, H. Obaid, and G. Plitas Neutrophil IL-10 suppresses peritoneal inflammatory monocytes during polymicrobial sepsis J Leukoc Biol 89 2011 423 432
21. V. Racanelli, and B. Rehermann The liver as an immunological organ Hepatology 43 2006 S54 62
22. T. Okaya, and A.B. Lentsch Cytokine cascades and the hepatic inflammatory response to ischemia and reperfusion J Invest Surg 16 2003 141 147
23. R.M. Zwacka, Y. Zhang, J. Halldorson, H. Schlossberg, L. Dudus, and J.F. Engelhardt CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver J Clin Invest 100 1997 279 289
24. L. Devey, D. Ferenbach, E. Mohr, K. Sangster, C.O. Bellamy, and J. Hughes Tissue-resident macrophages protect the liver from ischemia reperfusion injury via a heme oxygenase-1-dependent mechanism Mol Ther 17 2009 65 72
25. J.D. Ellett, C. Atkinson, Z.P. Evans, Z. Amani, E. Balish, and M.G. Schmidt Murine Kupffer cells are protective in total hepatic ischemia/reperfusion injury with bowel congestion through IL-10 J Immunol 184 2010 5849 5858
26. C.A. Bradham, R.F. Stachlewitz, W. Gao, T. Qian, S. Jayadev, and G. Jenkins Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases Hepatology 25 1997 1128 1135
27. T.P. Theruvath, C. Czerny, V.K. Ramshesh, Z. Zhong, K.D. Chavin, and J.J. Lemasters C-Jun N-terminal kinase 2 promotes graft injury via the mitochondrial permeability transition after mouse liver transplantation Am J Transplant 8 2008 1819 1828
28. T. Uehara, B. Bennett, S.T. Sakata, Y. Satoh, G.K. Bilter, and J.K. Westwick JNK mediates hepatic ischemia-reperfusion injury J Hepatol 42 2005 850 859
29. A.B. Imaeda, A. Watanabe, M.A. Sohail, S. Mahmood, M. Mohamadnejad, and F.S. Sutterwala Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome J Clin Invest 119 2009 305 314
30. E. Gabele, M. Muhlbauer, C. Dorn, T.S. Weiss, M. Froh, and B. Schnabl Role of TLR9 in hepatic stellate cells and experimental liver fibrosis Biochem Biophys Res Commun 376 2008 271 276
31. M. Abu-Amara, S.Y. Yang, N. Tapuria, B. Fuller, B. Davidson, and A. Seifalian Liver ischemia/reperfusion injury: processes in inflammatory networks - a review Liver Transpl 16 2010 1016 1032
32. T. Uehara, X. Xi Peng, B. Bennett, Y. Satoh, G. Friedman, and R. Currin c-Jun N-terminal kinase mediates hepatic injury after rat liver transplantation Transplantation 78 2004 324 332
33. M. Kobayashi, I. Takeyoshi, D. Yoshinari, K. Matsumoto, and Y. Morishita p38 mitogen-activated protein kinase inhibition attenuates ischemia-reperfusion injury of the rat liver Surgery 131 2002 344 349
34. D. Yoshinari, I. Takeyoshi, M. Kobayashi, T. Koyama, K. Iijima, and S. Ohwada Effects of a p38 mitogen-activated protein kinase inhibitor as an additive to university of Wisconsin solution on reperfusion injury in liver transplantation Transplantation 72 2001 22 27
35. M. Saraiva, and A. O'Garra The regulation of IL-10 production by immune cells Nat Rev Immunol 10 2010 170 181
36. I. Gotoh, M. Adachi, and E. Nishida Identification and characterization of a novel MAP kinase kinase kinase, MLTK J Biol Chem 276 2001 4276 4286
37. G.L. Johnson, and K. Nakamura The c-jun kinase/stress-activated pathway: regulation, function and role in human disease Biochim Biophys Acta 1773 2007 1341 1348
38. K.A. Sauter, E.A. Magun, M.S. Iordanov, and B.E. Magun ZAK is required for doxorubicin, a novel ribotoxic stressor, to induce SAPK activation and apoptosis in HaCaT cells Cancer Biol Ther 10 2010 258 266
39. P.W. Manley, N. Stiefl, S.W. Cowan-Jacob, S. Kaufman, J. Mestan, and M. Wartmann Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib Bioorg Med Chem 18 2010 6977 6986
40. D.L. White, V.A. Saunders, P. Dang, J. Engler, A.C. Zannettino, and A.C. Cambareri OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib Blood 108 2006 697 704
41. K.M. Irvine, C.J. Burns, A.F. Wilks, S. Su, D.A. Hume, and M.J. Sweet A CSF-1 receptor kinase inhibitor targets effector functions and inhibits pro-inflammatory cytokine production from murine macrophage populations FASEB J 20 2006 1921 1923
42. R.T. Sasmono, D. Oceandy, J.W. Pollard, W. Tong, P. Pavli, and B.J. Wainwright A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse Blood 101 2003 1155 1163
43. R.T. Paniagua, O. Sharpe, P.P. Ho, S.M. Chan, A. Chang, and J.P. Higgins Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis J Clin Invest 116 2006 2633 2642
44. R.T. Paniagua, A. Chang, M.M. Mariano, E.A. Stein, Q. Wang, and T.M. Lindstrom c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritis Arthritis Res Ther 12 2010 R32
45. J.G. Conway, B. McDonald, J. Parham, B. Keith, D.W. Rusnak, and E. Shaw Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580 Proc Natl Acad Sci USA 102 2005 16078 16083
46. B. Knight, J.E. Tirnitz-Parker, and J.K. Olynyk C-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in mice Gastroenterology 135 2008 969 979 979 e961
47. Y. Liu, Z. Wang, S.Q. Kwong, E.L. Lui, S.L. Friedman, and F.R. Li Inhibition of PDGF, TGF-beta, and Abl signaling and reduction of liver fibrosis by the small molecule Bcr-Abl tyrosine kinase antagonist Nilotinib J Hepatol 55 2011 612 625
48. K. Mizunuma, H. Ohdan, H. Tashiro, Y. Fudaba, H. Ito, and T. Asahara Prevention of ischemia-reperfusion-induced hepatic microcirculatory disruption by inhibiting stellate cell contraction using rock inhibitor Transplantation 75 2003 579 586
49. N.M. Jameel, C. Thirunavukkarasu, N. Murase, M. Cascio, J. Prelich, and S. Yang Constitutive release of powerful antioxidant-scavenging activity by hepatic stellate cells: protection of hepatocytes from ischemia/reperfusion injury Liver Transpl 16 2010 1400 1409